Phase III trial of gefitinib versus docetaxel in patients with previously treated advanced non-small-cell lung cancer

Latha Shivakumar, David Lee, Aarati Ranganathan, David R. Gandara, Roy S. Herbst, Corey J. Langer, Primo N. Lara

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)527-528
Number of pages2
JournalClinical Lung Cancer
Issue number9
StatePublished - Nov 2007

ASJC Scopus subject areas

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this